EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Correlation of CLDN18.2 and Tumor Microenvironment in Gastric Cancer: A Systematic Review

Katerina Zarampouka iD, Christos Tsiantas iD, Maria Athanasia Stavropoulou, Konstantinos Efthymiadis iD, Paschalis Theotokis iD, Sofia Gargani iD, Eleni Vrettou, Triantafyllia Koletsa iD, Maria Eleni Manthou iD, Soultana Meditskou iD

Cancers · 24.06.2025 · 17 (13) · 2120

DOI: 10.3390/cancers17132120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.06.2025. Verfasst von Katerina Zarampouka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Gastric cancer (GC) is the fifth leading cause of cancer-related mortality. CLDN18.2 is a tight junction protein, expressed in gastric mucosa and is considered as a novel therapeutic target. Even though CLDN18.2 is associated with various components of the tumor microenvironment and the relation with clinical histopathological parameters has been widely studied, there is no sufficient data on the associations of CLDN18.2 expression and the components of the tumor microenvironment. This systematic review aims to gather and present all available data about the correlation of CLDN 18.2 expression and the tumor microenvironment.

Methods

The research questions were systematically formulated using the PICO model to ensure clarity and precision, and the PRISMA flow diagram was constructed to detail the study selection process.

Results

Sixteen original articles were retrieved. The major finding of this study was the positive correlation between CLDN18.2 expression and CD8+ T cells, neutrophils and cancer-associated fibroblasts. No correlation was found between CLDN18.2 expression and Tregs and B cells. For the remaining components of the microenvironment, there are contradictory data about their correlation with the expression of CLDN18.2.

Conclusions

The tumor microenvironment plays a critical role in cancer progression and needs to be studied more thoroughly.

Schlagwörter

Stichwörter der Autor:innen

CLDN18.2gastric cancertumor microenvironment

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Laboratory of Histology-Embryology, Department of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Katerina Zarampouka, Christos Tsiantas, Konstantinos Efthymiadis, Paschalis Theotokis, Sofia Gargani, Triantafyllia Koletsa, Maria Eleni Manthou, Soultana Meditskou

Zitieren

APA

Zarampouka, K., Tsiantas, C., Stavropoulou, M. A., Efthymiadis, K., Theotokis, P., Gargani, S., Vrettou, E., Koletsa, T., Manthou, M. E., & Meditskou, S. (2025). Correlation of CLDN18.2 and Tumor Microenvironment in Gastric Cancer: A Systematic Review. Cancers, 17(13), 2120. https://doi.org/10.3390/cancers17132120

Vancouver

Zarampouka K, Tsiantas C, Stavropoulou MA, Efthymiadis K, Theotokis P, Gargani S, et al. Correlation of CLDN18.2 and Tumor Microenvironment in Gastric Cancer: A Systematic Review. Cancers. 2025;17(13):2120. doi:10.3390/cancers17132120

BibTeX
@article{Zarampouka2025,
  author = {Zarampouka, Katerina and Tsiantas, Christos and Stavropoulou, Maria Athanasia and Efthymiadis, Konstantinos and Theotokis, Paschalis and Gargani, Sofia and Vrettou, Eleni and Koletsa, Triantafyllia and Manthou, Maria Eleni and Meditskou, Soultana},
  title = {Correlation of CLDN18.2 and Tumor Microenvironment in Gastric Cancer: A Systematic Review},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2120},
  doi = {10.3390/cancers17132120}
}
Kostenlos starten →